Basic Information
| RNALocate ID: | RLID-D:11000173 |
| RNA Symbol: | hsa-miR-758-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-758-3p |
| RNA ID: | miRBase:MIMAT0003879 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Endothelial cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003505 | Exosome | Plasma | 23663360 |
| RLID-D:11000554 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-758-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-68711 |
| MNDR | hsa-miR-758-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68712 |
| MNDR | hsa-miR-758-3p | Lymphoma | MNDR-E-MI-68713 |
| MNDR | hsa-miR-758-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68714 |
| MNDR | hsa-miR-758-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68715 |
| MNDR | hsa-miR-758-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68716 |
| MNDR | hsa-miR-758-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68717 |
| MNDR | hsa-miR-758-3p | Her2-receptor positive breast cancer | MNDR-E-MI-68718 |
| MNDR | hsa-miR-758-3p | Prostate cancer | MNDR-E-MI-68719 |
| MNDR | hsa-miR-758-3p | Alzheimer disease | MNDR-E-MI-68720 |
| MNDR | hsa-miR-758-3p | Dysautonomia familial | MNDR-E-MI-68721 |
| MNDR | hsa-miR-758-3p | Lung cancer | MNDR-E-MI-68722 |
| MNDR | hsa-miR-758-3p | Parkinson disease | MNDR-E-MI-68723 |
| MNDR | hsa-miR-758-3p | Breast cancer | MNDR-E-MI-68724 |
| MNDR | hsa-miR-758-3p | Thyroid cancer | MNDR-E-MI-68725 |
| MNDR | hsa-miR-758-3p | Pancreatic cancer | MNDR-E-MI-68726 |
| MNDR | hsa-miR-758-3p | Hepatitis C | MNDR-E-MI-68727 |
| MNDR | hsa-miR-758-3p | Melanoma | MNDR-E-MI-68728 |
| MNDR | hsa-miR-758-3p | Rectum adenocarcinoma | MNDR-E-MI-68729 |
| MNDR | hsa-miR-758-3p | Nephroblastoma | MNDR-E-MI-68730 |
| MNDR | hsa-miR-758-3p | Colon adenocarcinoma | MNDR-E-MI-68731 |
| MNDR | hsa-miR-758-3p | Prostate adenocarcinoma | MNDR-E-MI-68732 |
| MNDR | hsa-miR-758-3p | Carcinoma ductal breast | MNDR-E-MI-68733 |
| MNDR | hsa-miR-758-3p | Glioma | MNDR-E-MI-68734 |
| MNDR | hsa-miR-758-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-68735 |
| MNDR | hsa-miR-758-3p | Osteosarcoma | MNDR-E-MI-68736 |
| MNDR | hsa-miR-758-3p | Gastric adenocarcinoma | MNDR-E-MI-68737 |
| MNDR | hsa-miR-758-3p | Cervical squamous cell carcinoma | MNDR-E-MI-68738 |
| MNDR | hsa-miR-758-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-68739 |
| MNDR | hsa-miR-758-3p | Lung adenocarcinoma | MNDR-E-MI-68740 |
| MNDR | hsa-miR-758-3p | Adrenocortical carcinoma | MNDR-E-MI-68741 |
| MNDR | hsa-miR-758-3p | Thyroid carcinoma | MNDR-E-MI-68742 |
| MNDR | hsa-miR-758-3p | Ovarian carcinoma | MNDR-E-MI-68743 |
| MNDR | hsa-miR-758-3p | Bladder urothelial carcinoma | MNDR-E-MI-68744 |
| MNDR | hsa-miR-758-3p | Carcinoma renal cell | MNDR-E-MI-68745 |
| MNDR | hsa-miR-758-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-68746 |
| MNDR | hsa-miR-758-3p | Renal clear cell carcinoma | MNDR-E-MI-68747 |
| MNDR | hsa-miR-758-3p | Lung small cell carcinoma | MNDR-E-MI-68748 |
| MNDR | hsa-miR-758-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-68749 |
| MNDR | hsa-miR-758-3p | Breast invasive carcinoma | MNDR-E-MI-68750 |
| MNDR | hsa-miR-758-3p | Hepatocellular carcinoma | MNDR-E-MI-68751 |
| MNDR | hsa-miR-758-3p | Breast cancer her3+ negative | MNDR-E-MI-68752 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL2 | Homo sapiens | RR00219085 |
TOP